[Diagnostic challenges of pediatric gliomas; the role of molecular profiling in everyday diagnostics]
- PMID: 39657041
[Diagnostic challenges of pediatric gliomas; the role of molecular profiling in everyday diagnostics]
Abstract
Aim: This study aims to evaluate the diagnostic challenges and molecular aspects of pediatric gliomas, among the most common brain tumors in children, focusing on improving early detection and personalized treatment strategies.
Methods: We conducted a comprehensive review of recent literature, examining current diagnostic techniques, including imaging and histopathological analysis, alongside molecular profiling methods such as next-generation sequencing (NGS) and methylation profiling.
Results: The findings highlight significant diagnostic challenges due to the heterogeneity of pediatric gliomas. Molecular profiling has proven essential in identifying key genetic alterations, such as those in the H3F3A and MAPK pathway genes, offering insights into tumor behavior and therapeutic targets.
Conclusions: Early and accurate diagnosis of pediatric gliomas is hampered by their molecular diversity. Integrating molecular diagnostics with traditional methods is crucial for enhancing diagnostic accuracy and guiding personalized treatment approaches.
Similar articles
-
[Classification of gliomas. Current progress and perspectives].Nervenarzt. 2015 Jun;86(6):672, 674-6, 678-80, passim. doi: 10.1007/s00115-014-4223-3. Nervenarzt. 2015. PMID: 25989737 German.
-
Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma-Tailored Gene Panel.Brain Pathol. 2017 Mar;27(2):146-159. doi: 10.1111/bpa.12367. Epub 2016 Apr 19. Brain Pathol. 2017. PMID: 26919320 Free PMC article.
-
Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas.Brain Tumor Pathol. 2023 Apr;40(2):56-65. doi: 10.1007/s10014-023-00457-6. Epub 2023 Apr 1. Brain Tumor Pathol. 2023. PMID: 37004583 Review.
-
Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.Oncologist. 2017 Dec;22(12):1478-1490. doi: 10.1634/theoncologist.2017-0242. Epub 2017 Sep 14. Oncologist. 2017. PMID: 28912153 Free PMC article.
-
Exploiting molecular biology for diagnosis and targeted management of pediatric low-grade gliomas.Future Oncol. 2016 Jun;12(12):1493-506. doi: 10.2217/fon-2016-0039. Epub 2016 Apr 13. Future Oncol. 2016. PMID: 27072750 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical